These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
552 related items for PubMed ID: 32447641
1. Potential roles of lymphovascular space invasion based on tumor characteristics provide important prognostic information in T1 tumors with ER and HER2 positive breast cancer. Zhao Y, Yang N, Wang X, Huang Y, Zhou X, Zhang D. Clin Transl Oncol; 2020 Dec; 22(12):2275-2285. PubMed ID: 32447641 [Abstract] [Full Text] [Related]
2. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy. Tan QX, Qin QH, Yang WP, Mo QG, Wei CY. Int J Clin Exp Pathol; 2014 Dec; 7(10):6862-70. PubMed ID: 25400769 [Abstract] [Full Text] [Related]
3. Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma. Matsuo K, Sheridan TB, Mabuchi S, Yoshino K, Hasegawa K, Studeman KD, Im DD, Rosenshein NB, Roman LD, Sood AK. Gynecol Oncol; 2014 Jun; 133(3):473-9. PubMed ID: 24674832 [Abstract] [Full Text] [Related]
4. Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer. Kondov B, Kondov G, Spirovski Z, Milenkovikj Z, Colanceski R, Petrusevska G, Pesevska M. Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Mar 01; 38(1):81-90. PubMed ID: 28593885 [Abstract] [Full Text] [Related]
5. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors. Qi G, Zhang X, Gai X, Yan X. PeerJ; 2024 Mar 01; 12():e17377. PubMed ID: 38766488 [Abstract] [Full Text] [Related]
6. Clinicopathologic characteristics and prognostic factors in patients with operable HER-2 overexpressing breast cancer. Liu AN, Sun P, Liu JN, Ma JB, Qu HJ, Zhu H, Yu CY, Zhang LM. Asian Pac J Cancer Prev; 2012 Mar 01; 13(4):1197-201. PubMed ID: 22799305 [Abstract] [Full Text] [Related]
7. Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information. Feeley LP, Mulligan AM, Pinnaduwage D, Bull SB, Andrulis IL. Mod Pathol; 2014 Apr 01; 27(4):554-61. PubMed ID: 24051696 [Abstract] [Full Text] [Related]
8. Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer. Dekker TJ, van de Velde CJ, van Bruggen D, Mesker WE, van der Hoeven JJ, Kroep JR, Tollenaar RA, Smit VT. Ann Oncol; 2013 Dec 01; 24(12):2994-8. PubMed ID: 24114856 [Abstract] [Full Text] [Related]
9. Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study. Shokouh TZ, Ezatollah A, Barand P. Medicine (Baltimore); 2015 Aug 01; 94(32):e1359. PubMed ID: 26266392 [Abstract] [Full Text] [Related]
10. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer. Jorge S, Hou JY, Tergas AI, Burke WM, Huang Y, Hu JC, Ananth CV, Neugut AI, Hershman DL, Wright JD. Gynecol Oncol; 2016 Mar 01; 140(3):387-93. PubMed ID: 26768835 [Abstract] [Full Text] [Related]
11. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes. Koca E, Kuzan TY, Dizdar O, Babacan T, Sahin I, Ararat E, Altundag K. Med Oncol; 2013 Mar 01; 30(3):615. PubMed ID: 23729267 [Abstract] [Full Text] [Related]
12. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women. Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, Munsey B, Panella T, Orucevic A. Breast J; 2013 Mar 01; 19(1):22-30. PubMed ID: 23240985 [Abstract] [Full Text] [Related]
13. Prognostic Factors for Luminal B-like Breast Cancer. Ding NH, Liu CF, Hu C, Yuan JQ, Liao WH, Xiao Z. Curr Med Sci; 2019 Jun 01; 39(3):396-402. PubMed ID: 31209809 [Abstract] [Full Text] [Related]
14. Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers. Fujimoto Y, Watanabe T, Hida AI, Higuchi T, Miyagawa Y, Ozawa H, Bun A, Fukui R, Sata A, Imamura M, Hirota S, Miyoshi Y. Breast Cancer; 2019 Nov 01; 26(6):738-747. PubMed ID: 31098866 [Abstract] [Full Text] [Related]
16. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China. Guan D, Jie Q, Wu Y, Xu Y, Hong W, Meng X. World J Surg Oncol; 2022 Sep 29; 20(1):326. PubMed ID: 36175898 [Abstract] [Full Text] [Related]
17. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N. Gynecol Oncol; 2005 Mar 29; 96(3):651-7. PubMed ID: 15721407 [Abstract] [Full Text] [Related]
20. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients. Kassem L, Deygas M, Fattet L, Lopez J, Goulvent T, Lavergne E, Chabaud S, Carrabin N, Chopin N, Bachelot T, Gillet G, Treilleux I, Rimokh R. BMC Cancer; 2015 Jun 04; 15():453. PubMed ID: 26040677 [Abstract] [Full Text] [Related] Page: [Next] [New Search]